WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.35%)Nav, as on 30-03-2026

  • Previous Nav

  • Net Change on 30-03-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 1.74 21.97 14.46 1.81 8,306.35
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 1.16 25.44 16.27 1.86 6,801.16
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 0.94 24.33 16.41 1.93 4,076.67
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -3.80 20.17 13.52 1.94 3,033.42
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 3.57 23.63 15.12 1.93 2,843.74

Fund Holdings as on 28-February-2026

  • Sun Pharmaceutical Industries Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Max Healthcare Institute Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Laurus Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Clearing Corporation of India Ltd

  • Sai Life Sciences Limited

  • Ajanta Pharma Limited

  • Corona Remedies Limited

  • Acutaas Chemicals Limited

  • IPCA Laboratories Limited

  • Narayana Hrudayalaya Limited

  • Shaily Engineering Plastics Limited

  • Pfizer Limited

  • Emcure Pharmaceuticals Limited

  • Navin Fluorine International Limited

  • AstraZeneca Pharma India Limited

  • Neuland Laboratories Limited

  • Kovai Medical Center and Hospital Limited

  • Aurobindo Pharma Limited

  • Aether Industries Limited

  • Strides Pharma Science Limited

  • Dr. Lal Path Labs Limited

  • Vijaya Diagnostic Centre Limited

  • Thyrocare Technologies Limited

  • 91 Days Tbill (MD 22/05/2026)

  • Supriya Lifescience Limited

  • Sudeep Pharma Limited

  • 91 Days Tbill (MD 12/03/2026)

  • Net Receivables / (Payables)

  • Zota Health Care Limited

  • Aarti Pharmalabs Limited

  • Abbott India Limited

  • Alkem Laboratories Limited

  • Shilpa Medicare Limited

  • Zydus Lifesciences Limited

  • Dr.Agarwals Eye Hospital Limited

  • Torrent Pharmaceuticals Limited

  • Poly Medicure Limited

  • Orchid Pharma Limited

  • Tatva Chintan Pharma Chem Limited

  • 364 Days Tbill (MD 19/03/2026)

  • 364 Days Tbill (MD 07/05/2026)

  • 91 Days Tbill (MD 14/05/2026)

  • 182 Days Tbill (MD 19/03/2026)

  • 182 Days Tbill (MD 09/04/2026)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Plastic Products

  • Trading

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹533.05 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.18(-1.35%)yesterday to ₹13.39.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643